Fiorella Schischlik

14PUBLICATIONS
69CO-AUTHORS
Molecular targetsApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Predictive and prognostic markersGene expression (incl. microarray and other genome-wide approaches)Cancer genetics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (14)

|Dec 23, 2024
Pan-KRAS Inhibitors BI-2493 and BI-2865 Display Potent Antitumor Activity in Tumors with KRAS Wild-type Allele Amplification.

Antonio Tedeschi, Fiorella Schischlik, Francesca Rocchetti

|Nov 07, 2024
TMED inhibition suppresses cell surface PD-1 expression and overcomes T cell dysfunction.

David W Vredevoogd, Georgi Apriamashvili, Pierre L Levy

|Oct 26, 2024
Ten challenges and opportunities in computational immuno-oncology.

Riyue Bao, Alan Hutson, Anant Madabhushi

|Aug 08, 2024
Inferring Characteristics of the Tumor Immune Microenvironment of Patients with HNSCC from Single-Cell Transcriptomics of Peripheral Blood.

Yingying Cao, Tiangen Chang, Fiorella Schischlik

|Dec 04, 2023
Transcriptional control of leukemogenesis by the chromatin reader SGF29.

Karina Barbosa, Anagha Deshpande, Marlenne Perales

|Jan 11, 2023
Preclinical optimization of a GPC2-targeting CAR T-cell therapy for neuroblastoma.

Ming Sun, Yingying Cao, Reona Okada

Pageof 3